Renu Sharaf Mansukhani, M.D.
NPI 1801042791ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Fairfax, VA
Opted out of Medicare from March 2018 to March 2028. Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Fairfax, Virginia, licensed in VA, with an NPI issued in August 2008. Part D covered 68 prescriptions written in 2024. Novo Nordisk Inc was the largest of 4 companies reporting payments in 2025, $287.75 in all, mostly food and beverage.
Overview
| NPI | 1801042791 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Aug 12, 2008 |
| Last updated in NPPES | Mar 12, 2018 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | 0101230546 | VA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Mar 12, 2018 – Mar 12, 2028 |
| Can order and refer | Yes |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Part D prescriptions in 2024
| Prescriptions (claims) | 68 · 139 30-day fills |
|---|---|
| Patients | 15 |
| Total drug cost | $21,708 |
Industry payments (Open Payments)
- 2025$287.75 · 10 payments from 4 companies
- 2024$290.74 · 12 payments from 4 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $162.46 | 4 |
| Lilly USA, LLC | $67.98 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $38.03 | 2 |
| Intercept Pharmaceuticals, Inc. | $19.28 | 1 |
What the 2025 payments were for
- Food and Beverage$287.75 · 10 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Fairfax
- 1164529343
- 1356696082
- 1881792240
- 1467749440
- 1811107162
- 1750380887
- 1265850903
- 1700053824
- 1639509821
- 1750394755
- 1558308502
- 1720475734
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Virginia →